Biotech

Israeli health-tech conference opens in Jerusalem with 1,800 participants from 40 countries

MIXiii Health-Tech.IL 2026 brought together investors, doctors, researchers, startups and global health-tech leaders, with a focus on Israeli emergency medicine, tech-bio, and technologies.

Jerusalem Mayor Moshe Lion, IATI CEO and President Karin Mayer Rubinstein and Teva executive Mark Sabag attend the opening of MIXiii Health-Tech.IL 2026 in Jerusalem.
In the photo (from left): Karin Mayer Rubinstein, CEO and President of the Israel Advanced Technology Industries Association (IATI), and Dror Bin, CEO of the Israel Innovation Authority.

Israeli life sciences investments fell 40% in 2025, report found

 The four-story ‘Clore Person, with inflatable organs that are activated by climbing inside the giant statue

Startup wants to grow “headless humans” to replace lab animals

Noam Solomon, CEO of Immunai, is using AI technology to map a key part of the human physiology – the immune system – and help discover and develop therapeutics that will ultimately save lives.

Israeli mathematician uses AI to decode human immune system


Jerusalem as our biotech capital: The city’s ascent as an innovation hub - opinion

Jerusalem's transformation is the outcome of long-term strategic policy, targeted public investment, and a thriving academic ecosystem.

 Jerusalem from above.

Is former truck mechanic Tim Friede may be key in creating anti-venom biotech

Friede's subjected himself to over 200 snake bites.

 Cobra snake.

Former Pfizer R&D chief Mikael Dolsten joins Immunai’s board of directors

Dolsten brings decades of pharmaceutical leadership to advance AI-driven drug discovery.

Tel Aviv startup Immunai aim to map the immune system

MNDL Bio wins award for the most innovative biotech solution in the Middle East

The startup company MNDL Bio has been named the winner of the Most Innovative Biotech Solution in the Middle East award.

 MNDL Bio

Phage virus discovered at Hebrew University named after fallen soldier

Phages are viruses that precisely target and kill bacteria, which can offer “a potential solution to the growing crisis of antibiotic resistance.”

 An aerial view of Hebrew University of Jerusalem's Mount Scopus campus.

The unique challenges integrating AI into biotechnology - opinion

According to Start-Up Nation Central (SNC), AI represents about 30% of Israel’s start-ups and attracts nearly half of total company funding.

 Artificial Intelligence Illustration

Immunai and Teva partner to innovate new cancer, immunology therapies

The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.

 An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017.

Aardvark tech track gives gap year students an opportunity to take part in the start up nation

The Inside Israeli Innovation Podcast with guest hosts Ellie Esquenazi and Corey Tusak: Season 2, Episode 34.

 Guests hosts Ellie Esquenazi and Corey Tusak

For the first time: The great women's conference of the Jerusalem hi-tech

First-ever "Women at the Front" conference in Jerusalem for 250 senior women in tech on Sept 22 at JVP complex. AI, career management, and more.

 Liron Dover, Director of Hi-Tech and Bio-Tech at the Jerusalem Development Authority

Achievement: Japanese pharma firm invests in Israeli cell startup

Japanese pharma company Astellas Venture Management invests in Israeli startup Somite AI, expanding pre-seed round with over $10 million in fundraising for innovative stem cell treatments using AI.

 The founders of Somite AI